SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-17-303852
Filing Date
2017-10-05
Accepted
2017-10-05 07:16:03
Documents
3
Period of Report
2017-10-03
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d468957d8k.htm 8-K 14648
2 EX-99.1 d468957dex991.htm EX-99.1 10326
3 GRAPHIC g468957g89x52.jpg GRAPHIC 3397
  Complete submission text file 0001193125-17-303852.txt   30923
Mailing Address 35 GATEHOUSE DRIVE BUILDING D, FLOOR 3 WALTHAM MA 02451
Business Address 35 GATEHOUSE DRIVE BUILDING D, FLOOR 3 WALTHAM MA 02451 781-419-1400
Syndax Pharmaceuticals Inc (Filer) CIK: 0001395937 (see all company filings)

IRS No.: 320162505 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37708 | Film No.: 171123270
SIC: 2834 Pharmaceutical Preparations